These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 24878909)
1. [Strategy for the prevention of papillomavirus related diseases. Substantiation of a programmatic decision in Chile]. Moreno G Rev Chilena Infectol; 2014 Apr; 31(2):204-6. PubMed ID: 24878909 [No Abstract] [Full Text] [Related]
2. [Cancer of cervix in Chile. Too much vaccine amid a neglected Papanicolau]. Fica A Rev Chilena Infectol; 2014 Apr; 31(2):196-203. PubMed ID: 24878908 [TBL] [Abstract][Full Text] [Related]
3. Prevention of HPV disease burden. Lehtinen M; Nieminen P; Apter D; Paavonen J Womens Health (Lond); 2014 Jul; 10(4):341-3. PubMed ID: 25259894 [No Abstract] [Full Text] [Related]
4. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model. Gomez JA; Lepetic A; Demarteau N BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus, current vaccines, and cervical cancer prevention. Teitelman AM; Stringer M; Averbuch T; Witkoski A J Obstet Gynecol Neonatal Nurs; 2009; 38(1):69-80. PubMed ID: 19208050 [TBL] [Abstract][Full Text] [Related]
6. In response to: Human papillomavirus screening for low and middle-income countries. Schiffman M Prev Med; 2017 Jul; 100():297-298. PubMed ID: 28583663 [No Abstract] [Full Text] [Related]
7. The economic impact of HPV vaccines: not just cervical cancer. Myers ER Am J Obstet Gynecol; 2008 May; 198(5):487-8. PubMed ID: 18455522 [No Abstract] [Full Text] [Related]
8. Policy debate over human papillomavirus vaccines. Richman S J Low Genit Tract Dis; 2009 Apr; 13(2):128. PubMed ID: 19387138 [No Abstract] [Full Text] [Related]
9. Human papillomavirus vaccines: an outsider's point of view. Trollfors B Expert Rev Vaccines; 2008 Oct; 7(8):1131-3. PubMed ID: 18844585 [No Abstract] [Full Text] [Related]
10. Towards global prevention of human papillomavirus-induced cancer. Roden RB; Gravitt P; Wu TC Eur J Immunol; 2008 Feb; 38(2):323-6. PubMed ID: 18228245 [No Abstract] [Full Text] [Related]
11. Going global against cervical cancer. Dougherty E Cancer Discov; 2013 Mar; 3(3):246. PubMed ID: 23475864 [No Abstract] [Full Text] [Related]
12. Debate begins over public funding for HPV vaccine. Comeau P CMAJ; 2007 Mar; 176(7):913-4. PubMed ID: 17374749 [No Abstract] [Full Text] [Related]
13. Human papillomavirus. Brody H Nature; 2012 Aug; 488(7413):S1. PubMed ID: 22932432 [No Abstract] [Full Text] [Related]
14. Latin America. Price is the main barrier to wider use of papillomavirus vaccine. Kaiser J Science; 2008 May; 320(5878):860. PubMed ID: 18487164 [No Abstract] [Full Text] [Related]
15. Human papilloma virus vaccines and current controversy. Choudhury P; John TJ Indian Pediatr; 2010 Aug; 47(8):724-5. PubMed ID: 20972294 [No Abstract] [Full Text] [Related]
17. Two doses and not three for the human papilloma virus vaccine in Chile. Bachelet VC Medwave; 2016 Jan; 16(1):e6373. PubMed ID: 26938044 [No Abstract] [Full Text] [Related]
18. Global human papillomavirus vaccination: can it be cost-effective? Crosbie EJ BJOG; 2012 Jan; 119(2):125-8. PubMed ID: 22168760 [No Abstract] [Full Text] [Related]
19. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient. Guo F; Hirth JM; Berenson AB J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084 [TBL] [Abstract][Full Text] [Related]
20. Three provinces to study 2-dose HPV vaccine. Eggertson L CMAJ; 2007 Aug; 177(5):444-5. PubMed ID: 17724315 [No Abstract] [Full Text] [Related] [Next] [New Search]